Australia Tissue Diagnostics Market Size & Outlook

The tissue diagnostics market in Australia is expected to reach a projected revenue of US$ 247.8 million by 2030. A compound annual growth rate of 8.8% is expected of Australia tissue diagnostics market from 2024 to 2030.
Revenue, 2023 (US$M)
$137.2
Forecast, 2030 (US$M)
$247.8
CAGR, 2024 - 2030
8.8%
Report Coverage
Australia

Australia tissue diagnostics market highlights

  • The Australia tissue diagnostics market generated a revenue of USD 137.2 million in 2023 and is expected to reach USD 247.8 million by 2030.
  • The Australia market is expected to grow at a CAGR of 8.8% from 2024 to 2030.
  • In terms of segment, immunohistochemistry was the largest revenue generating technology in 2023.
  • Digital Pathology and Workflow is the most lucrative technology segment registering the fastest growth during the forecast period.

Tissue diagnostics market data book summary

Market revenue in 2023USD 137.2 million
Market revenue in 2030USD 247.8 million
Growth rate8.8% (CAGR from 2023 to 2030)
Largest segmentImmunohistochemistry
Fastest growing segmentDigital Pathology and Workflow
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImmunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology
Key market players worldwideRoche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic

Other key industry trends

  • In terms of revenue, Australia accounted for 1.7% of the global tissue diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China tissue diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 526.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Tissue Diagnostics Market Companies

Name Profile # Employees HQ Website

Australia tissue diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.


Immunohistochemistry was the largest segment with a revenue share of 25.73% in 2023. Horizon Databook has segmented the Australia tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology, molecular pathology covering the revenue growth of each sub-segment from 2018 to 2030.


  • Australia Tissue Diagnostics Technology Outlook (Revenue, USD Million, 2018-2030)
    • Immunohistochemistry
      • Instruments
        • Slide Staining Systems
        • Tissue Microarrays
        • Tissue Processing Systems
        • Slide Scanners
        • Cell Processors
        • Microtomes
        • Embedding Systems
        • Cover Slippers
        • Other Products
      • Consumables
        • H&E stainer coverslipper
        • IHC stainer coverslipper
        • Antibodies
        • Others IHC reagents
      • Software
    • In situ Hybridization
      • Instruments
        • Stainers
        • Others
      • Consumables
      • Software
    • Primary & Special Staining
    • Digital Pathology and Workflow
      • Image Analysis Informatics
      • Information Management System Storage & Communication
    • Anatomic Pathology
      • Instruments
        • Microtomes & Cryostat microtomes
        • Tissue processors
        • Automatic strainers
        • Microscopes
        • Other Products
      • Consumables
        • Reagents & Antibodies
        • Probes & Kits
        • Others
    • Molecular Pathology
      • Instruments
      • Reagents
        • Fluorescence Reagents
        • Others
      • Others
  • Australia Tissue Diagnostics Application Outlook (Revenue, USD Million, 2018-2030)
    • Breast Cancer
    • Non Small Cell Lung Cancer
    • Prostate Cancer
    • Other Cancers
    • Gastric Cancer
  • Australia Tissue Diagnostics End use Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals
    • Diagnostic center
    • Pharmaceutical Organizations
    • CRO
  • Australia Tissue Diagnostics Modality Outlook (Revenue, USD Million, 2018-2030)
    • Clinical market
    • Pharma / CRO / Research market

Reasons to subscribe to Australia tissue diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia tissue diagnostics market databook

  • Our clientele includes a mix of tissue diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia tissue diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia tissue diagnostics market size, by technology, 2018-2030 (US$M)

Australia Tissue Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

Australia tissue diagnostics market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more